Drug companies accused of ignoring Ebola

Analysts say lack of financial incentive is holding back pharmaceutical firms from researching cure for deadly disease.

Multinational pharmaceutical companies have been accused of not doing enough to find a cure for the deadly Ebola virus.

The disease has killed more than 1,200 in West Africa, but analysts say drug firms lack motivation to research for a treatment because there is little financial incentive.

Al Jazeera’s Rob Reynolds reports from Washington.

Source: Al Jazeera

More from Economy
Most Read